Combinations of AKT inhibitor compounds and abiraterone, and methods of use

摘要

The invention provides a combination of a) a compound of Formula (Ia): or a pharmaceutically acceptable salt thereof, and b) abiraterone or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.;

主权项

1. A combination of a) a compound of Formula Ia:or a pharmaceutically acceptable salt thereof, and b) abiraterone or a pharmaceutically acceptable salt thereof, or abiraterone acetate or a pharmaceutically acceptable salt thereof.